ORBIMED ADVISORS LLC 13D and 13G filings for Galecto, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2023-09-18 4:19 pm Sale | 2023-09-12 | 13D | Galecto, Inc. GLTO | ORBIMED ADVISORS LLC | 29,982 2.800% | -16,005![]() (-34.80%) | Filing |
2023-09-05 4:20 pm Sale | 2023-08-30 | 13D | Galecto, Inc. GLTO | ORBIMED ADVISORS LLC | 45,988 4.200% | -18,315![]() (-28.48%) | Filing |
2023-08-17 4:30 pm Sale | 2023-08-15 | 13D | Galecto, Inc. GLTO | ORBIMED ADVISORS LLC | 64,303 5.900% | -25,354![]() (-28.28%) | Filing |
2023-08-02 5:02 pm Sale | 2023-07-31 | 13D | Galecto, Inc. GLTO | ORBIMED ADVISORS LLC | 89,658 8.300% | -8,568![]() (-8.72%) | Filing |
2023-07-17 4:11 pm Sale | 2023-07-13 | 13D | Galecto, Inc. GLTO | ORBIMED ADVISORS LLC | 98,226 9.600% | -9,641![]() (-8.94%) | Filing |
2023-04-07 4:38 pm Sale | 2023-04-05 | 13D | Galecto, Inc. GLTO | ORBIMED ADVISORS LLC | 107,866 10.500% | -2,992![]() (-2.70%) | Filing |
2020-11-06 5:12 pm Purchase | 2020-10-29 | 13D | Galecto, Inc. GLTO | ORBIMED ADVISORS LLC | 110,858 11.300% | 110,858![]() (New Position) | Filing |